Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine.

Barrera J, Brake DA, Schutta C, Ettyreddy D, Kamicker BJ, Rasmussen MV, Bravo de Rueda C, Zurita M, Pisano M, Hurtle W, Brough DE, Butman BT, Harper BG, Neilan JG.

Open source

DOI
10.1016/j.vaccine.2018.10.031
Published
2018-10-13
Container
Vaccine
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.vaccine.2018.10.031,
  title = {Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine.},
  author = {Barrera J and  Brake DA and  Schutta C and  Ettyreddy D and  Kamicker BJ and  Rasmussen MV and  Bravo de Rueda C and  Zurita M and  Pisano M and  Hurtle W and  Brough DE and  Butman BT and  Harper BG and  Neilan JG.},
  year = {2018},
  journal = {Vaccine},
  doi = {10.1016/j.vaccine.2018.10.031},
  url = {https://doi.org/10.1016/j.vaccine.2018.10.031}
}

RIS

TY  - JOUR
TI  - Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine.
AU  - Barrera J
AU  -  Brake DA
AU  -  Schutta C
AU  -  Ettyreddy D
AU  -  Kamicker BJ
AU  -  Rasmussen MV
AU  -  Bravo de Rueda C
AU  -  Zurita M
AU  -  Pisano M
AU  -  Hurtle W
AU  -  Brough DE
AU  -  Butman BT
AU  -  Harper BG
AU  -  Neilan JG.
PY  - 2018
JO  - Vaccine
DO  - 10.1016/j.vaccine.2018.10.031
UR  - https://doi.org/10.1016/j.vaccine.2018.10.031
ER  - 

APA

J, B., DA, B., C, S., D, E., BJ, K., MV, R., C, B. D. R., M, Z., M, P., W, H., DE, B., BT, B., BG, H., & JG., N. (2018). Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine.. Vaccine. https://doi.org/10.1016/j.vaccine.2018.10.031

Source records